ANALYST RECOMMENDATIONS : Amgen, Banner, Merck, Oracle, Phoenix...
Every day, find a selection of analysts' recommendations covering North America and the U.K. The list only includes companies that have been the subject of a change of opinion or price target, or a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain shares or the market sentiment on a company.
- Admiral: JPMorgan reduced the price target of Admiral Group to 27.10 pounds sterling from 27.30 pounds and reiterated its neutral rating.
- Amgen: Morgan Stanley cut its recommendation to equal-weight from overweight. PT rises 10% to $85
- Asos: Goldman Sachs is keeping its Buy rating. The target price is reduced from GBp 6100 to GBp 5800.
- Banner: D.A. Davidson & Co downgrades Banner Corp. to neutral from buy. PT up 6.2 % to $60
- Cirrus Logic: Barclays upgrades to overweight from equal-weight. PT gains 20% to $100
- EnQuest: Jefferies upgraded from buy to hold with a target of 24 GBp.
- Merck & Co: Morgan Stanley downgrades to equal-weight from overweight. PT up 10% to $85
- Oracle: Jefferies retains its Neutral opinion on the stock. The target price has been revised upwards and is now set at USD 95, compared with USD 80 previously.
- Phoenix group: JPMorgan lowered the price target of Phoenix Group to 7.09 pounds sterling from 7.93 pounds and maintained its neutral rating.
By 
